Defunct Company
Total Trials
19
As Lead Sponsor
18
As Collaborator
1
Total Enrollment
59,360
NCT00984945
Safety Study of a Plant-based H5 Virus-Like Particles (VLP) Vaccine in Healthy Adults
Phase: Phase 1
Role: Lead Sponsor
Start: Sep 30, 2009
Completion: Jul 31, 2010
NCT01244867
Immunogenicity, Safety, Tolerability of a Plant-Made H5 VLP Influenza Vaccine
Phase: Phase 2
Start: Nov 30, 2010
Completion: Sep 30, 2011
NCT01302990
Safety, Tolerability and Immunogenicity of a Plant-Made H1 VLP Influenza Vaccine in Adults
Start: Feb 28, 2011
Completion: Nov 30, 2011
NCT01657929
H5-VLP + GLA-AF Vaccine Trial in Healthy Adult Volunteers
Role: Collaborator
Start: Sep 30, 2012
Completion: Jan 31, 2014
NCT01991561
Immunogenicity, Safety, Tolerability of a Plant-made H5 Virus-like-particle (VLP) Influenza Vaccine.
Start: Jun 30, 2013
Completion: Nov 30, 2014
NCT01991587
Safety, Tolerability and Immunogenicity of a Plant-made Seasonal Quadrivalent VLP Influenza Vaccine in Adults
Phase: Phase 1/2
Start: Oct 8, 2013
Completion: Jun 30, 2014
NCT02022163
Safety, Tolerability and Immunogenicity of a Plant-made H7 Virus-like Particle (VLP) Influenza Vaccine in Adults.
Start: Dec 31, 2013
Completion: Dec 31, 2014
NCT02236052
Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal VLP Quadrivalent Influenza Vaccine in the Elderly Population
Start: Jul 16, 2014
Completion: Jun 17, 2015
NCT02233816
Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal Virus-Like-Particle Quadrivalent Influenza Vaccine in Adults
Start: Jul 28, 2014
Completion: Jun 22, 2015
NCT02768805
Immunogenicity of a Quadrivalent Virus-Like Particles (VLP) Influenza Vaccine in Healthy Adults
Start: Mar 2, 2016
Completion: Nov 26, 2016
NCT02831751
Immunogenicity, Safety, and Tolerability of a Plant-Derived Quadrivalent VLP Influenza Vaccine in Elderly Adults
Start: Apr 30, 2016
Completion: Jan 31, 2017
NCT03301051
Efficacy, Safety, and Immunogenicity of a Plant-Derived Quadrivalent Virus-Like Particles (VLPs) Influenza Vaccine in Adults
Phase: Phase 3
Start: Aug 31, 2017
Completion: May 9, 2018
NCT03321968
Lot-to-lot Consistency of a Plant-Derived Quadrivalent Virus-Like Particles Influenza Vaccine in Healthy Adults
Start: Sep 29, 2017
Completion: Dec 1, 2017
NCT03739112
Efficacy of a Plant-derived Quadrivalent Virus-like Particle (VLP) Vaccine in the Elderly
Start: Sep 18, 2018
Completion: Jul 16, 2019
NCT04450004
Safety, Tolerability and Immunogenicinity of a Coronavirus-Like Particle COVID-19 Vaccine in Adults Aged 18-55 Years.
Start: Jul 10, 2020
Completion: Aug 30, 2021
NCT04622592
Adjuvanted Seasonal Recombinant Quadrivalent Virus-Like Particles (QVLP) Influenza Vaccine in Adults 65 Years of Age and Older
Start: Nov 2, 2020
Completion: Apr 26, 2022
NCT04636697
Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults
Phase: Phase 2/3
Start: Nov 19, 2020
Completion: Apr 30, 2022
NCT05065619
Safety Immunogenicity Study of MT-2766 in Japanese Adults（COVID-19）
Start: Oct 2, 2021
Completion: Jan 29, 2023
NCT05040789
Phase 3 Study to Evaluate the Lot Consistency of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine
Start: Nov 22, 2021
Completion: May 31, 2022